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THE results of renal transplantation in black recipients hav'c becn conflicting. Many reports have described 
inferior graft survival in blacks. I.12 Other reports have shown 
no difference between black and white recipients. D. I' The 
reason for these disparate findings is not clear. Speculation 
has centered around the response to cyclosporine,lo HLA and 
Lewis antigen matching differences,'·IO.12 and the center 
effect. II .ll 
Two other important issues in renal transplantation con-
cern organ allocation and immunosuppressive management. 
In 1986. the point system was implemented at the University 
of Pittsburgh to provide end·stage renal disease (ESRD) 
patients with equal access to cadaver kidneys. II The system, 
developed in Pittsburgh and since adopted by the United 
:"etwork for Organ Sharing (UNOS). takes into account 
waiting time, number of HLA antigens matched. and the 
degree of sensitization. Medical urgency and logistical fac-
tors playa much smaller role. A recipient for a given kidney 
is selected according to rank on the list as determined by 
these objective criteria. Since race does not enter into 
consideration. the point system is formally color blind. 
In our most recent analyses of graft and patient survival 
after the introduction of the point system into clinical 
practice. we noted and confirmed the important effect of the 
immunosuppressive regimenKD9K~o The three·drug combina-
tion of c~closporineK azathioprine. and prednisone was associ-
ated with a 10 to 15% improvement in graft survival when 
compared with cyclosporine and prednisone alone. This 
observation held up in all subgroup analyses. including those 
of sc:nsitlzed patients. In thiS article, we present our experi-
ence with renal transplantation. looking specifically at the 
queslIon of patient and graft survival in black and white 
reCipients. We concern ourselves specifically with the 21/:_ 
:-ear period after the introduction of the point system. 
PATIENTS AND METHODS 
FiH hundred forty·mne renal transplantations were performed at 
the L ni, ersity of Pittsburgh Hospitals (Presbyterian-L:nlversity 
Hospital and Children's Hospital of Pittsburgh) between January I. 
1986. and June 30, 1988. Eight of the kidneys were from living 
relaled donors and ... ere excluded from analysis. Similarly excluded 
"'ere II cases of cadaver kidney transplantation in conjunction with 
a li"er or a heart transplant. There ... ere thus 530 consecutive cases 
a,ailable for analySIS. Seventy·live (142%) kidneys were trans· 
planted into black recipients; the total number of Hispanic and 
Asian reCipients was less than 1't of the total recipient population. 
These ligures are 10 close proportion to the local referral base in 
PllUburgh. 
O( the 450 adults. 383 EUR1~F were white and 67 E14K9~F were 
black. The)' received 413 and 71 transplants. respectively. The mean 
age _as 42.2: 12.9 years and 43.1 : 12.6 years. respectively. The 
most common disease of the native kidneys was chronic glomerulone-
phritis. ~inety-tive (23%) of the white adult recipients and 10 (14%) 
of the black adult recipients were diabetics. almost all type I. 
Three black children received 4 transplants. -hereas 37 white 
children recei\'ed 42 transplants; 3 of the black children and 23 of the 
white children were 10 to 18 years old. and no black children and 14 
white children were 6 months to 9 years old. 
Twenty·scven (5.1%) of the kidneys came from black donors. and 
503 (94.9<t) were from white donors. 
Tissue Typing 
The HLA typing for all donors and all recipients .. as carried out in 
an accredited laboratory in which all class I and class" antigens can 
be measured. Antidonor antibodies were systematically looked for. 
and crossmatches with recipient sera were performed in every case. 
Point Allocation System 
The Pittsburgh allocation system ranks potential recipients o( a 
given kidney on the basis of several factors." Waiting time, delined 
as beginning with the date of referral. can account (or up to 10 
points. Each class I or class" antigen match bet .. een donor and 
reCipient counts (or 2 points. for a potential total of 12 if there is 
complete Hl.:A identity. Every 10% of panel reactive antibody 
(PRA) counts for I point. for a potential total of 10 points. i( there 
are antibodies against all the lymphocyte test panel (100% PRA). 
Finally. medical urgency or logistic factors can add points. although 
these are rarely used. Thus. the system gives prtont~ to those who 
have waited the longest, those with the best antigen match. and those 
with the greatest degree of presensitization .... ho have a negative 
crossmatch. 
Immunosuppression 
During 1986. all patients were managed initiall~ "'uh cyclosporine 
and prednisone. In 1987. just under half o( the recipients were 
started on cyclosporine. azathioprine. and predni).)r.e. In 1988. all 
patients ... ere induced with the three·drug regimen Variations of 
this triple-drug regimen ",ere deSCribed in 1984 at the International 
Transplantation Society. or shortly thereafter.:: :. urlier. the com· 
bination of c~c1osporine and azathioprine had been tested in pri· 
mates by Reitz et alK:~ and synergism was demons!:Jted in rats and 
dogs by Squifflet et al.:· By the time of the 1986 meetmg in Helsinki 
of the International Transplantation Societ). mere than a dozen 
papers describing the advantages of three·drug or focr·drug therapy 
...ere presented. 
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under the point .y.t.m, 1986-1988. 
OKT3 was used for steriod·resistant rejection episodes.17 In some 
highly sensitized patients or cases of multiple retransplantation. 
OKT3 was used for induction. 
Statistical Methods 
Actuarial pattent and graft survivals .. ere calculated for the 2·year 
period. Statistical analysis was performed using BMDP software. 
Significance "as assessed by the Mantel·Cox or the Breslow test. 
RESULTS 
Patient Survival and Causes of Death 
Seventy black patients received 75 kidneys. and 420 white 
patients received 455 kidneys. The actuarial patient survival 
at I and 2 ~ears was 91~ in black patients; for white 
recipients it was 93% and 90% (Fig 1 ). Five (7.1 %) black and 
35 (8.4%) white recipients have died. The causes of death for 
black and white recipients are listed in Table I. In UM~ of the 
cases. there had been difficulty in maintaining good renal 
graft funclion (Table 1). either early. because of acute 
rejection. or later because of chronic rejection or other 
factors. Apart from this factor. the most common pnncipal 
cause of the events leading to death was infection. usually 
caused by opportunistic organisms or viruses. 
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Table 2. Matchln91n "91 c •••• In Which There Wa. 
Adequ.te Donor / R.clplent Typing 
No. 01 Antigena 
Malched Black White Tolal 
8 0 5/6 (83%) 5/8 (83%) 
5 0 3/5 (60%) 3/5 (60%) 
4 2/2 (100%) 12/17 (71%) 14/19 (74%) 
3 4/6 (67%) 41/67(81%) 45/73 (62%) 
2 13/16 (81%) 61/113 (72%) 94/129 (73%) 
1 19/24 (79%) 96/138 (70%) 1151162 (7 1 %) 
0 13/23 (57%) 47/74 (64%) 60/97 (62%) 
51/71 (72%) 285/420 (68%) 336/491 (68%) 
Graft Survival 
In black recipients. I· and 2-year actuarial graft survival was 
80% and 66%; the corresponding figures in the white popula-
tion were 72% and 67%. These percentages were not statisti-
cally different (Fig I). Although the sophisticated examina-
tion of tissue typing was not part of the study. there was no 
obvious effect of tissue matching (Table 2). The incidence of 
success was about the same in both blacks and whites with all 
levels of compatibility. Graft survival has been 4-30 months. 
Because some of the patients received more than one graft 
during the 1986 to 1988 study period. the actual number of 
patients represented by the 530 cadaveric transplantations 
was 490. Of the 490 patients. 450 (92%) are alive and 362 
(74%) are off dialysis (Table 3). The percentages for blacks 
and whites are nearly identical. Thus. a higher percentage of 
patients have a good result after renal transplantation than is 
indicated by actuarial graft survival. 
Donor Effect 
Twenty-seven kidneys from black donors were transplanted 
into 3 black and 24 white recipients. One·year graft survival 
was 100% and 58.3%. respectively (Table 4). Five hundred 
three kidneys from white donors were transplanted into 72 
black and 431 white recipients. One-year graft survival was 
Table 1. C.u ••• ot De.th Atter Renal Tran.plantatlon 
Cluleof D .. th 
Infection 
Cardiovascular 
Gastroinleslinal 
Resplratory 
Malignancy 
Technical 
Miscellaneous (D.l.e., multiple 
organ lallura, hyperkalemia. 
bleed after biopsy, molor 
vehlcle Iccldenl) 
Unknown 
TOIII 
Grand 10111 
B 
0 
0 
0 
0 
0 
0 
o 
o 
o 
Grill Functioning 
8 (20%) 
W 
1 
4 
1 
0 
0 
0 
2 
o 
8 
B 
4 
0 
1 
0 
0 
0 
o 
o 
5 
Grall Removed or 
Nonlunctlonlng 
W 
10 
5 
3 
2 
3 
2 
27 
32 (8O'lb) 
B 
4 
0 
1 
0 
0 
0 
o 
o 
5 
Tolal 
W 
11 
9 
4 
2 
5 
2 
35 
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Table 3. Fate of 70 Black Recipient. of 75 Gran. and 420 
White Recipient. of 455 Graft. 
Black Whit. Tol.1 
Alive 65 (92.9%) 385 (91.7%) 450 (91.8%) 
Of! dialysis 52 (74.3%) 310 (73.8%) 362 (73.9%) 
On dialysis 13 (18.6%) 75 (17.9%) 68 (17.9%) 
Oead 5(7.1%) 35 (8.3%) 40 (8.2%) 
79.2% and 72.2%. respectively. These figures were not 
statistically different. 
Adults vs Children 
Black and white adults and children did not differ signifi-
cantly in overall graft survival (Fig 2). None of 3 black 
children and 4 of 37 (10.8%) white children had died. with a 
mortality similar to that of adults. 
Primary Transplantation vs Retransplantation 
The results in transplanting pa lients for the first time were 
slightly but not significantly better than the results with 
retransplantation (Fig 3). Again. there was no difference 
between black and white recipients. 
Transplantation to Unsensitized vs Sensitized Patients 
Black patients with a PRA less than 4M~ had a significantly 
(p < 0.05) better survival than did blacks with a PRA 
greater than 40% (Fig 4). Similar results were noted in white 
recipients. This observation has been noted in most series. 
Ellect of Triple· vs Double·Drug Immunosuppression 
Beginning in January 1987. a subgroup of patients was 
treated with cyclosporine. azathioprine. and prednisone. and 
graft survival was found to be significantly better than with 
the cohort of patients receiving cycJosporine and steroids 
alone. Since January 1988. all patients have received triple-
drug immunosuppression. and the initially favorable results 
have continued. In the triple therapy group. actuarial 1·~ear 
graft survival has been 9SC:C and 80% in blacks and whites. 
respectively. and in those receiving double therapy. the 
corresponding figures are 75'1 and SU~ (p < 0.(07) (Fig ~FK 
Adults vs Children 
The advantage of triple·drug therapy was approximatel) the 
same whether the recipients were in the black or white adult 
or pediatric population (Figs 6 and 7). although the numbers 
in the pediatric group were too small to show statistical 
significance. 
Primary Transplantation vs Retransplantation 
In both black and white recipients. triple-drug immunosup-
pression was associated with improved I·year graft sUI'\'j"'al 
in primary grafts (p < 0.04) (Fig 8). There also appeared to 
be improved survival in retransplantation. although the 
numbers were too small to show statistical significance (Fig 
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" Table 4. The Donor Effect: Number of Kidney. Tran.planted 
and Percent Surviving at 1 Vear (by Race of Recipient, 
Rice of 
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White 
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:2 f-
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r 
o~ 
o 
RIC. of Recipi.nt 
Number of Kidney. 
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3 
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Fig 5. Grl" lurvlvIl, three-drug Ind two-drug 18munolup-
pr.llion In bllekl Ind whlt.l. 
9). Again. there was no difference between hacks and 
whites. 
Low vs High PRA 
Triple-drug therapy seemed to be somewhat ad\lntageous 
for sensitized black and white patients. Actua:-.al I·year 
graft survival was 75% and 79%, respectively, co:;pared to 
57% and 55% under double-drug treatment. Black lnd white 
recipients with low PRAs had an actuarial I-year wrvival of 
100% and 81 %. respectively, under triple·drug irr~unosup­
pression compared to 83% and 70% with double-c:ug treat-
ment (Figs 10 and II) (p < 0.004). There was no dference 
between black and white recipients. Thus triple-dT4 therapy 
upgraded survival in both the favorable and immun:logically 
unfavorable patient categories. 
DISCUSSION 
\1any articles have been published describing inf~or renal 
allograft survival in black recipients. ' ) 9.1) Multiple !'plana. 
tions have been offered. A few articles have dem:r.strated 
equivalent graft survival rates between blacks and \10 :ltes. IJ." 
In a review combining the results of many centers. Terasaki 
et al claim that the inferior graft survival in b:~;ks was 
mereh a center effect and that there was in fact :.) racial 
difference."') Specifically. they pointed out that I: centers 
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with "excellent" results, there were no differences between 
blacks and whites. In cenlers with "fair" results, graft 
survi\'al in blacks was inferior. The fact that more black 
recipients were transplanted in centers with fair results 
accounts for the overall poorer graft survival seen in blacks. 
Our experience under the point system demonstrated at 
least equivalent graft survival between black and white 
recipients. There was. in fact, a trend toward superior results 
in black recipients, but this difference was not statistically 
significant. The implications are reassuring in several dif-
ferent ways. Critics of the point system have argued that the 
goal of transplantation should be to maximize graft survival 
and the way to accomplish this is to transplant the "best" 
recipients, ie, those who are young and healthy and have low 
PRAs.:1 Kjellstrand's analysis has shown how this ad hoc 
selection process systematically excluded blacks from the 
"best" designation,:q In our previous reports of experience 
with the point system. we noted and confirmed that excellent 
patient and graft survival could be obtained under a system 
that ensured equal access to donor organs, In this regard, the 
important advantage of three-drug over two-drug immuno-
suppression was emphasized. An equitable allocation system 
ensures that black reCipients ",ill come to transplantation as 
often as while reCipients, Our results indicate that black and 
'" hite recipients have equally good results under such a 
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prallion In blackl and whit .. with PRA <40%. 
system. Furthermore, the effect of immunosuppressive proto-
col was seen in both blacks and ~ hites. 
The results seen in renal transplantation in blacks have 
generated enough controversy to lead to this conference. It is 
our hope that the demonstration of equally good results in 
black and white recipients with the point system will help to 
settle this issue:. 
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